Drug pricing has become one of the most volatile and politically charged issues facing health system pharmacy. This session unpacks the implications of current and proposed federal policies — including tariffs on pharmaceutical imports and pricing reform legislation — and examines what pharmacy leaders can do now to protect their formularies, manage cost exposure and stay ahead of a rapidly shifting policy landscape.